Terifitin M Sustained Release Tablet 10/500mg

Adult dose

This medication is generally administered once daily with dinner. The 20/1000mg sustained-release tablet is taken once daily at a dose of one tablet. The 10/750mg or 10/500mg sustained-release tablets are taken once daily at a dose of two tablets simultaneously. The initial dose provides teneligliptin 20mg once daily along with the existing dose of metformin. Sustained-release formulations must be swallowed whole without splitting, crushing, or chewing.

This medication is used for the treatment of diabetes and should not be administered to patients with poor kidney function or weak heart function. While taking this medication, there is a rare risk of developing lactic acidosis, a dangerous condition, so symptoms should be reported to medical personnel immediately. Also, caution should be exercised when taking this medication in conjunction with other diabetes medications such as insulin or sulfonylureas, as hypoglycemic symptoms may arise. This medication should be avoided or temporarily discontinued in patients with impaired liver function or those facing serious infections, trauma, or surgery. Women who are pregnant or may become pregnant are advised not to take this medication. Patients should be aware of the symptoms of hypoglycemia and lactic acidosis while taking this medication, and consult a doctor immediately if symptoms occur. Some patients may experience side effects such as dyspepsia, diarrhea, constipation, headache, dizziness, etc., so any unusual symptoms should be communicated to medical personnel. Additionally, it is important to regularly monitor kidney function and blood tests during the course of this medication. Alcohol consumption may increase the risk of side effects from this medication, so it should be avoided while taking it. Women who are breastfeeding should also be cautious while taking this medication and should discuss whether to continue breastfeeding with their doctor. Elderly patients may have decreased kidney function, so dosage adjustments and regular monitoring are necessary. Interactions with certain medications may occur while taking this medication, so patients should inform their doctor or pharmacist of any other medications they are taking. In case of overdose, seek immediate medical attention for appropriate treatment, including possible hemodialysis. The safety of this medication has not been established in children, thus it should not be used in pediatric patients. Store this medication in a tightly sealed container, out of reach of children, and do not transfer it to another container.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, peeling skin, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities with coughing + fever, yellowing of the skin or eyes (jaundice), extreme fatigue, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, urine

Mild side effects

• Dizziness
• constipation
• abdominal distension
• abdominal discomfort
• nausea
• abdominal pain
• bloating
• stomatitis
• gastric polyp
• colonic polyp

This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. The storage temperature should be maintained between 1 degree and 30 degrees Celsius at room temperature to safely maintain its effectiveness.

Appearance

Orange, egg-shaped sustained-release film-coated tablet

Package unit

30 tablets/bottle